thrombopoietin receptor agonists (Genomics Institute of the Novartis Research Foundation)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namethrombopoietin receptor agonists (Genomics Institute of the Novartis Research Foundation)
Drug Alias Namethrombopoietin receptor agonists (GNF)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThrombopoietin receptor agonists
TargetsThrombopoietin receptor
Therapy Area/IndicationsThrombocytopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenomics Institute of the Novartis Research Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenomics Institute of the Novartis Research Foundation
Active IndicationsN/A
Inactive IndicationsThrombocytopenia

Other Information

ATC CodeN/A
Related LinksN/A